Parkinson's Disease Trial, Recruiting NCT04375280 Sponsor: University Hospital, Clermont-Ferrand Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT04375280
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 90 years of age (men or women)
  • People who have a long-term health condition that affects their ability to move around
  • People who have given their written agreement to take part in the trial
  • People who are part of the French healthcare system (for sites based in France)

Who may not be able to join:

  • People with ongoing psychiatric conditions such as active psychosis or hallucinations, or another serious health condition that is not yet under control (such as severe heart failure or advanced terminal cancer)
  • People whose heart or blood vessel condition is poorly controlled or unstable
  • People with significant bone, joint, or nervous system problems that would completely prevent them from completing the trial's tests
  • People who are not able to manage their day-to-day activities independently
  • People who are under legal guardianship, curatorship, have restricted freedom, or are under a justice protection measure
  • People who are currently taking part in, or have been excluded from, another research study
  • Women who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Frédéric Costes, University Hospital, Clermont-Ferrand

Phone: 334.73.754.963

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
27 August 2020
Est. completion
26 August 2035

Where this trial is recruiting

🇫🇷 France

Primary endpoints

dismobility score calculated from the results reported in secondary outcomes; dismobility score calculated from the results reported in secondary outcomes; dismobility score calculated from the results reported in secondary outcomes; dismobility score calculated from the results reported in secondary outcomes; dismobility score calculated from the results reported in secondary outcomes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov